R&D Partner Content 8th Antigen-Specific Immune Tolerance Drug Development Summi... Building on 7 years of success, the 8th Antigen-Specific Immune Tolerance Summit is back - the only conference dedicated to advancing curative th
R&D Partner Content 2nd Protein Degradation for CNS Summit | Brand-New Program Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to undruggable CNS target
R&D Partner Content Proteomic Based Drug Discovery Summit 2025 Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
R&D Partner Content Less than three weeks away: Join Global Experts at Transderm... 11-12 November 2024 in London, UK
R&D Partner Content 4th mRNA Analytical Development & Quality Control Summit | F... Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
R&D Partner Content BIO-Europe's 30th Anniversary Landmark Event in Stockholm BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
Oncology ASCO 26: Three strong Pfizer Phase 3s, with Johanna Bendell Pharmaphorum caught up with Johanna Bendell, Pfizer’s chief development officer for oncology, to learn about what the company is bringing to ASCO.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.